Cargando…

Current clinical testing approach of COVID

December 2019, when the world was busy in welcoming New Year, unaware of the fact that the spark of COVID-19 has been ignited in Wuhan, China, will outbreak into wildfire to scorch the entire World. Nobody could have imagined that a single cell microorganism which even does not have any kind of cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhardwaj, Manisha, Kakkar, Priyanka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334984/
http://dx.doi.org/10.1016/B978-0-323-90280-9.00003-1
_version_ 1784759231216353280
author Bhardwaj, Manisha
Kakkar, Priyanka
author_facet Bhardwaj, Manisha
Kakkar, Priyanka
author_sort Bhardwaj, Manisha
collection PubMed
description December 2019, when the world was busy in welcoming New Year, unaware of the fact that the spark of COVID-19 has been ignited in Wuhan, China, will outbreak into wildfire to scorch the entire World. Nobody could have imagined that a single cell microorganism which even does not have any kind of cellular structure could be such a huge threat to human society. WHO and Public Health of Emergency of International Concern (PHEIC) declared COVID-19 as highly contagious within a month after reporting of the first case on January 11, 2020. As it started spreading across the globe, it was declared as a pandemic by WHO on March 12, 2020. Several scientists of government and nongovernment organizations started working toward the prevention and treatment of this novel disease. Its high rate of transmission, global spread, and high mortality rate started raising concerns worldwide. But as the disease was spreading at an extremely high rate through person-to-person contact, the main challenge was to develop fast and accurate diagnostic methods. Diagnostic tests during such pandemic are crucial as they help to evaluate the effectiveness of the prevention, treatment, and population-wise containment measures. This chapter discusses the various clinical methods that are currently being used worldwide to detect the presence of deadly Corona virus. The procedures of the tests are detailed and are compared based on their specificity, sensitivity, limit of detection (LOD), reliability, and affordability.
format Online
Article
Text
id pubmed-9334984
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-93349842022-07-29 Current clinical testing approach of COVID Bhardwaj, Manisha Kakkar, Priyanka Sensing Tools and Techniques for COVID-19 Article December 2019, when the world was busy in welcoming New Year, unaware of the fact that the spark of COVID-19 has been ignited in Wuhan, China, will outbreak into wildfire to scorch the entire World. Nobody could have imagined that a single cell microorganism which even does not have any kind of cellular structure could be such a huge threat to human society. WHO and Public Health of Emergency of International Concern (PHEIC) declared COVID-19 as highly contagious within a month after reporting of the first case on January 11, 2020. As it started spreading across the globe, it was declared as a pandemic by WHO on March 12, 2020. Several scientists of government and nongovernment organizations started working toward the prevention and treatment of this novel disease. Its high rate of transmission, global spread, and high mortality rate started raising concerns worldwide. But as the disease was spreading at an extremely high rate through person-to-person contact, the main challenge was to develop fast and accurate diagnostic methods. Diagnostic tests during such pandemic are crucial as they help to evaluate the effectiveness of the prevention, treatment, and population-wise containment measures. This chapter discusses the various clinical methods that are currently being used worldwide to detect the presence of deadly Corona virus. The procedures of the tests are detailed and are compared based on their specificity, sensitivity, limit of detection (LOD), reliability, and affordability. 2022 2022-07-29 /pmc/articles/PMC9334984/ http://dx.doi.org/10.1016/B978-0-323-90280-9.00003-1 Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bhardwaj, Manisha
Kakkar, Priyanka
Current clinical testing approach of COVID
title Current clinical testing approach of COVID
title_full Current clinical testing approach of COVID
title_fullStr Current clinical testing approach of COVID
title_full_unstemmed Current clinical testing approach of COVID
title_short Current clinical testing approach of COVID
title_sort current clinical testing approach of covid
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334984/
http://dx.doi.org/10.1016/B978-0-323-90280-9.00003-1
work_keys_str_mv AT bhardwajmanisha currentclinicaltestingapproachofcovid
AT kakkarpriyanka currentclinicaltestingapproachofcovid